{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T02:31:37Z","timestamp":1783391497289,"version":"3.54.6"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,4,7]],"date-time":"2010-04-07T00:00:00Z","timestamp":1270598400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s00535-010-0234-4","type":"journal-article","created":{"date-parts":[[2010,4,6]],"date-time":"2010-04-06T02:57:05Z","timestamp":1270522625000},"page":"885-895","source":"Crossref","is-referenced-by-count":50,"title":["Meta-analysis: somatostatin or its long-acting analogue, octreotide, for prophylaxis against post-ERCP pancreatitis"],"prefix":"10.1007","volume":"45","author":[{"given":"Fumio","family":"Omata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuharu","family":"Tokuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Ohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Carr-Locke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua L.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Mine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuguya","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,7]]},"reference":[{"key":"234_CR1","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0016-5107(04)00353-0","volume":"59","author":"ML Freeman","year":"2004","unstructured":"Freeman ML, Guda NM. Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc. 2004;59:845\u201364.","journal-title":"Gastrointest Endosc"},{"key":"234_CR2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000180981","volume":"29","author":"JM Bordas","year":"1988","unstructured":"Bordas JM, Toledo V, Mondelo F, Rodes J. Prevention of pancreatic reactions by bolus somatostatin administration in patients undergoing endoscopic retrograde cholangio-pancreatography and endoscopic sphincterotomy. Horm Res. 1988;29:106\u20138.","journal-title":"Horm Res"},{"key":"234_CR3","first-page":"271","volume":"2","author":"A Saari","year":"1988","unstructured":"Saari A, Kivilaakso E, Schroder T. The influence of somatostatin on pancreatic irritation after pancreatography. An experimental and clinical study. Surg Res Comm. 1988;2:271\u20138.","journal-title":"Surg Res Comm"},{"key":"234_CR4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0016-5107(91)70619-6","volume":"37","author":"M Guelrud","year":"1991","unstructured":"Guelrud M, Mendoza S, Viera L, Gelrud D. Somatostatin prevents acute pancreatitis after pancreatic duct sphincter hydrostatic balloon dilation in patients with idiopathic recurrent pancreatitis. Gastrointest Endosc. 1991;37:44\u20137.","journal-title":"Gastrointest Endosc"},{"key":"234_CR5","first-page":"259","volume":"39","author":"B Persson","year":"1992","unstructured":"Persson B, Slezak P, Efendic S, Haggmark A. Can somatostatin prevent injection pancreatitis after ERCP? Hepatogastroenterology. 1992;39:259\u201361.","journal-title":"Hepatogastroenterology"},{"key":"234_CR6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0016-5107(98)70318-9","volume":"47","author":"JM Bordas","year":"1998","unstructured":"Bordas JM, Toledo-Pimentel V, Llach J, Elena M, Mondelo F, Gines A, et al. Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: results of a randomized study. Gastrointest Endosc. 1998;47:230\u20134.","journal-title":"Gastrointest Endosc"},{"key":"234_CR7","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0016-5107(02)70431-8","volume":"56","author":"A Andriulli","year":"2002","unstructured":"Andriulli A, Clemente R, Solmi L, Terruzzi V, Suriani R, Sigillito A, et al. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. Gastrointest Endosc. 2002;56:488\u201395.","journal-title":"Gastrointest Endosc"},{"key":"234_CR8","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0016-5107(99)70387-1","volume":"49","author":"RT Poon","year":"1999","unstructured":"Poon RT, Yeung C, Lo CM, Yuen WK, Liu CL, Fan ST. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Gastrointest Endosc. 1999;49:593\u20138.","journal-title":"Gastrointest Endosc"},{"key":"234_CR9","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1440-1746.2003.03297.x","volume":"19","author":"D Arvanitidis","year":"2004","unstructured":"Arvanitidis D, Anagnostopoulos GK, Giannopoulos D, Pantes A, Agaritsi R, Margantinis G, et al. Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial. J Gastroenterol Hepatol. 2004;19:278\u201382.","journal-title":"J Gastroenterol Hepatol"},{"key":"234_CR10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1542-3565(04)00295-2","volume":"2","author":"A Andriulli","year":"2004","unstructured":"Andriulli A, Solmi L, Loperfido S, Leo P, Festa V, Belmonte A, et al. Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate. Clin Gastroenterol Hepatol. 2004;2:713\u20138.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"234_CR11","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/BF01296438","volume":"37","author":"KF Binmoeller","year":"1992","unstructured":"Binmoeller KF, Dumas R, Harris AG, Delmont JP. Effect of somatostatin analog octreotide on human sphincter of Oddi. Dig Dis Sci. 1992;37:773\u20137.","journal-title":"Dig Dis Sci"},{"key":"234_CR12","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJM199609263351302","volume":"335","author":"G Cavallini","year":"1996","unstructured":"Cavallini G, Tittobello A, Frulloni L, Masci E, Mariana A, Di Francesco V. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy\u2014Italian Group. N Engl J Med. 1996;335:919\u201323.","journal-title":"N Engl J Med"},{"key":"234_CR13","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0016-5107(95)70014-5","volume":"42","author":"GR Weiner","year":"1995","unstructured":"Weiner GR, Geenen JE, Hogan WJ, Catalano MF. Use of corticosteroids in the prevention of post-ERCP pancreatitis. Gastrointest Endosc. 1995;42:579\u201383.","journal-title":"Gastrointest Endosc"},{"key":"234_CR14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1572-0241.1998.061_c.x","volume":"93","author":"JA Dumot","year":"1998","unstructured":"Dumot JA, Conwell DL, O\u2019Connor JB, Ferguson DR, Vargo JJ, Barnes DS, et al. Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: a randomized, multicenter, placebo-controlled clinical trial. Am J Gastroenterol. 1998;93:61\u20135.","journal-title":"Am J Gastroenterol"},{"key":"234_CR15","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1067\/mge.2002.122614","volume":"55","author":"S Manolakopoulos","year":"2002","unstructured":"Manolakopoulos S, Avgerinos A, Vlachogiannakos J, Armonis A, Viazis N, Papadimitriou N, et al. Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial. Gastrointest Endosc. 2002;55:470\u20135.","journal-title":"Gastrointest Endosc"},{"key":"234_CR16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mge.2003.307","volume":"58","author":"S Sherman","year":"2003","unstructured":"Sherman S, Blaut U, Watkins JL, Barnett J, Freeman M, Geenen J, et al. Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study. Gastrointest Endosc. 2003;58:23\u20139.","journal-title":"Gastrointest Endosc"},{"key":"234_CR17","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/0026-0495(78)90066-5","volume":"27","author":"S Raptis","year":"1978","unstructured":"Raptis S, Schlegel W, Lehmann E, Dollinger HC, Zoupas C. Effects of somatostatin on the exocrine pancreas and the release of duodenal hormones. Metabolism. 1978;27:1321\u20138.","journal-title":"Metabolism"},{"key":"234_CR18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-0028-1093677","volume":"8","author":"HC Dollinger","year":"1976","unstructured":"Dollinger HC, Raptis S, Pfeiffer EF. Effects of somatostatin on exocrine and endocrine pancreatic function stimulated by intestinal hormones in man. Horm Metab Res. 1976;8:74\u20138.","journal-title":"Horm Metab Res"},{"key":"234_CR19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0140-6736(77)90182-9","volume":"2","author":"W Schlegel","year":"1977","unstructured":"Schlegel W, Raptis S, Harvey RF, Oliver JM, Pfeiffer EF. Inhibition of cholecystokinin-pancreozymin release by somatostatin. Lancet. 1977;2:166\u20138.","journal-title":"Lancet"},{"key":"234_CR20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/bjs.1800720516","volume":"72","author":"JN Baxter","year":"1985","unstructured":"Baxter JN, Jenkins SA, Day DW, Roberts NB, Cowell DC, Mackie CR, et al. Effects of somatostatin and a long-acting somatostatin analogue on the prevention and treatment of experimentally induced acute pancreatitis in the rat. Br J Surg. 1985;72:382\u20135.","journal-title":"Br J Surg"},{"key":"234_CR21","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1136\/gut.52.12.1768","volume":"52","author":"RT Poon","year":"2003","unstructured":"Poon RT, Yeung C, Liu CL, Lam CM, Yuen WK, Lo CM, et al. Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial. Gut. 2003;52:1768\u201373.","journal-title":"Gut"},{"key":"234_CR22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/MPA.0b013e3181733721","volume":"37","author":"KT Lee","year":"2008","unstructured":"Lee KT, Lee DH, Yoo BM. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial. Pancreas. 2008;37:445\u20138.","journal-title":"Pancreas"},{"key":"234_CR23","first-page":"1561","volume":"87","author":"JM Sternlieb","year":"1992","unstructured":"Sternlieb JM, Aronchick CA, Retig JN, Dabezies M, Saunders F, Goosenberg E, et al. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis. Am J Gastroenterol. 1992;87:1561\u20136.","journal-title":"Am J Gastroenterol"},{"key":"234_CR24","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1055\/s-2007-1009081","volume":"26","author":"R Arcidiacono","year":"1994","unstructured":"Arcidiacono R, Gambitta P, Rossi A, Grosso C, Bini M, Zanasi G. The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy. Endoscopy. 1994;26:715\u20138.","journal-title":"Endoscopy"},{"key":"234_CR25","first-page":"115","volume":"53","author":"M Duvnjak","year":"1999","unstructured":"Duvnjak M, Supanc V, Simicevic VN, Hrabar D, Troskot B, Smircic-Duvnjak L, et al. Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography. Acta Med Croatica. 1999;53:115\u20138.","journal-title":"Acta Med Croatica"},{"key":"234_CR26","first-page":"165","volume":"5","author":"PD Hardt","year":"2000","unstructured":"Hardt PD, Kress O, Fadgyas T, Doppl W, Schnell-Kretschmer H, Wusten O, et al. Octreotide in the prevention of pancreatic damage induced by endoscopic sphincterotomy. Eur J Med Res. 2000;5:165\u201370.","journal-title":"Eur J Med Res"},{"key":"234_CR27","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.gie.2006.03.934","volume":"64","author":"KC Thomopoulos","year":"2006","unstructured":"Thomopoulos KC, Pagoni NA, Vagenas KA, Margaritis VG, Theocharis GI, Nikolopoulou VN. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis. Gastrointest Endosc. 2006;64:726\u201331.","journal-title":"Gastrointest Endosc"},{"key":"234_CR28","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.gie.2006.10.030","volume":"65","author":"A Andriulli","year":"2007","unstructured":"Andriulli A, Leandro G, Federici T, Ippolito A, Forlano R, Iacobellis A, et al. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis. Gastrointest Endosc. 2007;65:624\u201332.","journal-title":"Gastrointest Endosc"},{"key":"234_CR29","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1440-1746.2007.04928.x","volume":"22","author":"D Rudin","year":"2007","unstructured":"Rudin D, Kiss A, Wetz RV, Sottile VM. Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trials. J Gastroenterol Hepatol. 2007;22:977\u201383.","journal-title":"J Gastroenterol Hepatol"},{"key":"234_CR30","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1365-2036.2009.03991.x","volume":"29","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Chen QB, Gao ZY, Xie WF. Meta-analysis: octreotide prevents post-ERCP pancreatitis, but only at sufficient doses. Aliment Pharmacol Ther. 2009;29:1155\u201364.","journal-title":"Aliment Pharmacol Ther"},{"key":"234_CR31","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264\u20139, W64."},{"key":"234_CR32","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ"},{"key":"234_CR33","unstructured":"Juni P, Altman DG, Egger M. Meta-analysis in Stata. In: Egger M, Smith G, Altman D, editors. Systematic Reviews in Health Care British medical journal. 2003. p. 90."},{"key":"234_CR34","unstructured":"Sterne J, Bradburn M, Egger M. Meta-analysis in Stata. In: Egger M, Smith G, Altman D, editors. Systematic Reviews in Health Care British medical journal. 2003. p. 200."},{"key":"234_CR35","first-page":"9","volume":"40","author":"M Duvnjak","year":"2001","unstructured":"Duvnjak M, Supanc V, \u0160imi\u010devi\u0107 V, Hrabar D, Troskot B, Smir\u010di\u0107-Duvnjak L, et al. A randomized, double-blind trial of the efficacy of octreotide acetate administration in the prevention of abdominal pain. Acta Clin Croat. 2001;40:9\u201313.","journal-title":"Acta Clin Croat"},{"key":"234_CR36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0016-5107(91)70620-2","volume":"37","author":"Z Tulassay","year":"1991","unstructured":"Tulassay Z, Papp J. The effect of long-acting somatostatin analogue on enzyme changes after endoscopic pancreatography. Gastrointest Endosc. 1991;37:48\u201350.","journal-title":"Gastrointest Endosc"},{"key":"234_CR37","first-page":"265","volume":"17","author":"GF Cicero","year":"1985","unstructured":"Cicero GF, Laugier R, Sahel J, Manganaro M, Sarles H. Effects of somatostatin on clinical, biochemical and morphological changes following ERCP. Ital J Gastroenterol. 1985;17:265\u20138.","journal-title":"Ital J Gastroenterol"},{"key":"234_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0016-5107(00)70377-4","volume":"51","author":"A Andriulli","year":"2000","unstructured":"Andriulli A, Leandro G, Niro G, Mangia A, Festa V, Gambassi G, et al. Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. Gastrointest Endosc. 2000;51:1\u20137.","journal-title":"Gastrointest Endosc"},{"key":"234_CR39","first-page":"109","volume":"35","author":"G B\u00f6rsch","year":"1984","unstructured":"B\u00f6rsch G, Bergbauer M, Nebel W, Sabin G. Effect of somatostatin on amylase level and pancreatitis rate following ERCP. Med Welt. 1984;35:109\u201312.","journal-title":"Med Welt"},{"key":"234_CR40","first-page":"70","volume":"20","author":"PA Testoni","year":"1988","unstructured":"Testoni PA. Endoscopic papillo-sphincterotomy: prevention of pancreatic reaction by somatostatin. Ital J Gastroenterol. 1988;20:70\u20133.","journal-title":"Ital J Gastroenterol"},{"key":"234_CR41","first-page":"17","volume":"74","author":"G Flati","year":"1988","unstructured":"Flati G, Porowska B, Negro P, Flati D, Chiarinelli ML, Carboni M. Effect of somatostatin on the sequelae of endoscopic retrograde cholangiopancreatography. Rev Esp Enferm Apar Dig. 1988;74:17\u20139.","journal-title":"Rev Esp Enferm Apar Dig"},{"key":"234_CR42","doi-asserted-by":"crossref","first-page":"A149","DOI":"10.1016\/S0016-5107(89)72755-3","volume":"35","author":"K Deschner","year":"1989","unstructured":"Deschner K, Kalloo A, Collen M, Cattau EL, Maher KA, et al. Somatostatin: an evaluation of its utility as adjunctive medication for ERCP. Gastrointest Endosc. 1989;35:A149.","journal-title":"Gastrointest Endosc"},{"key":"234_CR43","first-page":"139","volume":"15","author":"A Russo","year":"1992","unstructured":"Russo A, Virgilio C, Aprile G, Magnano A, Cosentino S. Influenza dell\u2019octreotide sulla reazione pancraticaa indotta da colangiopancreatografia retrograda (Effect of octreotide on pancreatic reactions following ERCP). Giorn Ital End Dig. 1992;15:139\u201345.","journal-title":"Giorn Ital End Dig"},{"key":"234_CR44","first-page":"431","volume":"26","author":"PA Testoni","year":"1994","unstructured":"Testoni PA, Lella F, Bagnolo F, Buizza M, Colombo E. Controlled trial of different dosages of octreotide in the prevention of hyperamylasemia induced by endoscopic papillosphincterotomy. Ital J Gastroenterol. 1994;26:431\u20136.","journal-title":"Ital J Gastroenterol"},{"key":"234_CR45","first-page":"359","volume":"15","author":"G Baldazzi","year":"1994","unstructured":"Baldazzi G, Conti C, Spotti EG, Arisi GP, Scevola M, Gobetti F, et al. Prevention of post-ERCP acute pancreatitis with octreotide. G Chir. 1994;15:359\u201362.","journal-title":"G Chir"},{"key":"234_CR46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00006676-199607000-00008","volume":"13","author":"PA Testoni","year":"1996","unstructured":"Testoni PA, Lella F, Bagnolo F, Caporuscio S, Cattani L, Colombo E, et al. Long-term prophylactic administration of octreotide reduces the rise in serum amylase after endoscopic procedures on Vater\u2019s papilla. Pancreas. 1996;13:61\u20135.","journal-title":"Pancreas"},{"key":"234_CR47","first-page":"248","volume":"45","author":"D Arvanitidis","year":"1998","unstructured":"Arvanitidis D, Hatzipanayiotis J, Koutsounopoulos G, Frangou E. The effect of octreotide on the prevention of acute pancreatitis and hyperamylasemia after diagnostic and therapeutic ERCP. Hepatogastroenterology. 1998;45:248\u201352.","journal-title":"Hepatogastroenterology"},{"key":"234_CR48","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S1590-8658(06)80037-X","volume":"38","author":"S Benvenuti","year":"2006","unstructured":"Benvenuti S, Zancanell L, Piazzi L, Comberlato M, Chilovi F, Germana B, et al. Prevention of post-ERCP pancreatitis with somatostatin versus gabexate mesilate: a randomized placebo-controlled multicenter study. Dig Liver Dis. 2006;38:S15.","journal-title":"Dig Liver Dis"},{"key":"234_CR49","doi-asserted-by":"crossref","unstructured":"Badra G, Galal AS, Rowaisha I, Waked I, Moustafa MS, Saleh SM. Allopurinol vs octreotide in the prevention of post-ERCP pancreatitis in patients with biliary obstruction. A randomized controlled trial. Hepatology 2000;32:163A.","DOI":"10.1016\/S0002-9270(00)01414-3"},{"key":"234_CR50","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1046\/j.1365-2036.2001.01015.x","volume":"15","author":"PA Testoni","year":"2001","unstructured":"Testoni PA, Bagnolo F, Andriulli A, Bernasconi G, Crotta S, Lella F, et al. Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicenter, randomized, controlled trial. Aliment Pharmacol Ther. 2001;15:965\u201372.","journal-title":"Aliment Pharmacol Ther"},{"key":"234_CR51","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1572-0241.2006.00959.x","volume":"102","author":"ZS Li","year":"2007","unstructured":"Li ZS, Pan X, Zhang WJ, Gong B, Zhi FC, Guo XG, et al. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: a multicenter, placebo-controlled, randomized clinical trial. Am J Gastroenterol. 2007;102:46\u201351.","journal-title":"Am J Gastroenterol"},{"key":"234_CR52","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.cgh.2007.07.008","volume":"5","author":"A Sofuni","year":"2007","unstructured":"Sofuni A, Maguchi H, Itoi T, Katanuma A, Hisai H, Niido T, et al. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent. Clin Gastroenterol Hepatol. 2007;5:1339\u201346.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"234_CR53","first-page":"88","volume-title":"Exploring between study heterogeneity. Methods for meta-analysis in medical research","author":"A Sutton","year":"2000","unstructured":"Sutton A, Abrams K, Jones D, Sheldon T, Song F. Exploring between study heterogeneity. Methods for meta-analysis in medical research. New York: Wiley; 2000. p. 88."}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-010-0234-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-010-0234-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-010-0234-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:37:48Z","timestamp":1559083068000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-010-0234-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,7]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["234"],"URL":"https:\/\/doi.org\/10.1007\/s00535-010-0234-4","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,7]]}}}